SAS and R (?) for variability comparison (FDA NTID Guidance) [General Sta­tis­tics]

posted by jag009  – NJ, 2015-09-25 22:42  – Posting: # 15473
Views: 18,364

Hi,

» 4. Since FDA request that only subject who complete all 4 periods should be included in the analysis, for obtaining F-distribution value, it seems the degree of freedom vT and vR will always be equal, which is always Ntotal - 2 for full replicate. Right?

Where did you see this? I don't see it in the guidance. However, if you use FDA's SAS code (ie: Progesterone) to extract the variances etc etc, you WILL see that the code only takes subjects who completed both periods for Test and Ref. Example, any subjects who finished only 1T out of 2Ts will be dropped.

Take a look at previous threads involving the Concerta guidance (I started that thread and a few joined in. Sorry I don't have time to set the link now. Need to go party). :-D

Lastly, as to why you get reverse upper and lower limit with the interval, I will try and goof around in SAS next week and see.

John


Edit: The threads John mentioned above: #13991, #14150. [Helmut]

Complete thread:

Activity
 Admin contact
20,250 posts in 4,262 threads, 1,397 registered users;
online 20 (0 registered, 20 guests [including 9 identified bots]).
Forum time (Europe/Vienna): 10:22 CET

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5